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A B S T R A C T
Objectives: To start a surveillance program to investigate the possible diffusion of mobilized colistin
resistance genes in Enterobacteriaceae strains isolated in the Unit of Microbiology of the Great Romagna
Hub Laboratory.
Methods: All the colistin resistant Enterobacteriaceae, isolated from August 1st 2016 to July 31st 2017,
were prospectively evaluated for mcr-1 and mcr-2. Backdated survey of mcr-3, mcr-4 and mcr-5 was
performed on the same group of isolates. Species identification was achieved by Vitek MS and the
antibiotic susceptibility testing was performed both with Vitek-2 and Sensititre systems. Colistin
resistant isolates were screened by PCR for the presence of the plasmid-mediated colistin resistance
genes and amplicons were verified by sequencing. All mcr-1 positive isolates were subjected to MLST
analysis.
Results: Over the total of 19053 isolates belonging to Enterobacteriaceae, 90 were colistin resistant. The
presence of mcr-1 was detected in 26 Escherichia coli. The overall prevalence of mcr-1 was 0.14%. The mcr-
1 positive E. coli strains were assigned to 13 distinct sequence types (STs) according to MLST.
Conclusions: The prospective epidemiological survey carried out in our study gave a glimpse of the
plasmid-mediated colistin resistance dissemination in Romagna. Since the prevalence rate of
carbapenem resistant Enterobacteriaceae (CRE) in some hospital wards in our area is alarming, we
underline the importance of a Surveillance Program to monitor the spread of the plasmid-mediated
colistin resistance genes into MDR Gram-negative bacteria.
© 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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journal homepage: www.elsevier .com/ locate / i j idEnterobacteriaceae are responsible for a significant number of
infections and deaths worldwide, and the prevalence of antibiotic
resistance continues to rise in these bacteria (World Health
Organization, 2014). Colistin is nowadays reported as one of the
last line antimicrobial drugs active against multidrug-resistant
gram-negative bacteria (MDR). This renewed therapeutic role is
now potentially hampered by four plasmidic genes mcr-1, mcr-2,
mcr-3, mcr-4 and mcr-5 that mediate the resistance to colistin (Liu
et al., 2016; Xavier et al., 2016; Yin et al., 2017; Carattoli et al., 2017;
Borowiak et al., 2017).
In July 2016 we were informed by the Institute for Experimental
Veterinary Medicine of Lombardy and Emilia-Romagna that a* Corresponding author at: U.O. Microbiologia - Laboratorio Unico del Centro
Servizi - AUSL della Romagna, Piazza della Liberazione 60, Pievesestina, Cesena, IT
47522, Italy.
E-mail address: francescadelbianco@outlook.com (F. Del Bianco).
https://doi.org/10.1016/j.ijid.2018.02.006
1201-9712/© 2018 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Salmonella enterica isolated in January 2015 from a 3 year old
patient in our Laboratory, was bearing the mcr-1 gene. This isolate
was included in a retrospective analysis performed on human and
veterinary Salmonella spp. isolates in Emilia Romagna (Carnevali
et al., 2016). A surveillance program to investigate the possible
diffusion of mcr-1 and mcr-2 genes in humans was promptly
started. All the colistin resistant Enterobacteriaceae, prospectively
isolated from clinical specimens from August 1st 2016 to July 31st
2017 were evaluated. A specific analysis for mcr -3, mcr-4 and mcr-5
was performed on the same colistin resistant isolates in later
stages.
The bacteria identification was carried out by the standard
procedure (Vitek-MS; BioMérieux, Marcy l’Etoile, France). The
minimum inhibitory concentrations (MICs) were determined with
the Vitek 2 (BioMérieux; AST-card N201) according to The
European Committee on Antimicrobial Susceptibility Testing
(EUCAST) rules. Out of a total of 19053 non-duplicateciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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strains displayed colistin MICs of  2 mg/L. In 90 cases the
resistance was confirmed through a microdilution method (TREK
Sensititre custom panel GNX2F; Thermo-Fisher TREK Diagnostic
Systems, Cleveland, OH, USA) as recommended by a joint EUCAST
and CLSI subcommittee (www.eucast.org/ast_of_bacteria/warn-
ings/). These 90 strains included E. coli (n = 63), Klebsiella
pneumoniae (n = 22), Enterobacter cloacae (n = 4) and Hafnia alvei
(n = 1). The isolates were first screened for mcr-1 and mcr-2 genes
by PCR. PCR assays were performed as described previously (Liu
et al., 2016; Xavier et al., 2016) mcr-1 was detected in 26 isolates, all
E. coli (26/12441, 0.21% overall for this species), whereas no mcr-2
was found. Confirmation and allele identification were carried out
by bidirectional DNA sequencing. The amplified sequences were
100% homologous with the phosphoethanolamine transferase
sequence reported worldwide (Liu et al., 2016). mcr-3, mcr-4 and
mcr-5 were discovered after the start of our surveillance program.
In order to implement the mcr-screening, the 90 colistin resistant
strains collected from August 1st 2016 to July 31st 2017 were tested
for mcr-3, mcr-4, mcr-5. PCR assays were performed as reported
previously (Yin et al., 2017; Carattoli et al., 2017; Borowiak et al.,
2017): none of the three genes was detected.
Out of 26 mcr-1 positive strains, 16 were isolated from
outpatients while 10 were from hospitalized patients. These were
cultured from urine in 21 cases, from blood in 2 cases, in 2 cases
from a wound swab, and in 1 case from bronchial aspirate. MICs for
colistin ranged from 4 mg/L (n = 4) to 8 mg/L (n = 22) and the
isolates were susceptible to the majority of antimicrobial agent
tested. Table 1 shows the details about MICs of the individual
strains.
In addition, two strains (3O/RA; 19O/CE) showed also an
extended-spectrum b-lactamase phenotype (ESbLs). KeyTable 1
Features of the mcr-1-harboring E. coli clinical isolates. MICs were determinated by Vit
Strain Isolation Source MLSTa MIC mg/L (S/I/R)b
AMK AMX/CLAV CTX CFT 
1O/RA Aug 2016 urine ST617 2 S 2 S 1 S 1 S 
2I/RN Aug 2016 urine ST744 2 S 8 S 1 S 1 S 
3O/RA ESbL+c Sept 2016 urine ST73 2 S 16 R 2 I 16 R 
4O/RA Sept 2016 urine ST410 2 S 32 R 1 S 1 S 
5I/RA Sept 2016 blood ST624 2 S 32 R 1 S 1 S 
6I/RN Sept 2016 urine ST224 2 S 16 R 1 S 1 S 
7I/RN Sept 2016 urine ST69 2 S 2 S 1 S 1 S 
8I/CE Sept 2016 urine ST69 4 S 16 R 1 S 1 S 
9O/RA Sept 2016 urine ST457 2 S 4 S 1 S 1 S 
10O/FO Sept 2016 urine ST10 2 S 4 S 1 S 1 S 
11O/RA Sept 2016 wounde ST354 2 S 8 S 1 S 1 S 
12O/RA Sept 2016 urine ST10 2 S 4 S 1 S 1 S 
13I/RN Oct 2016 urine ST224 2 S 16 R 1 S 1 S 
14O/RN Oct 2016 urine ST10 2 S 32 R 1 S 1 S 
15O/FO Nov 2016 urine ST216 2 S 8 S 1 S 1 S 
16O/RA Nov 2016 urine ST95 2 S 4 S 1 S 1 S 
17O/RA Oct 2016 urine ST744 2 S 2 S 1 S 1 S 
18I/RN Dec 2016 blood ST10 2 S 16 R 1 S 1 S 
19O/CE ESbL+c,d Dec 2016 urine ST131 2 S 4 S 8 R 1 S 
20O/RA Jan 2017 urine ST131 2 S 4 S 1 S 1 S 
21I/RN Feb 2017 urine ST10 2 S 2 S 1 S 1 S 
22O/FO Apr 2017 urine ST131 2 S 2 S 1 S 1 S 
23O/RA Apr 2017 urine ST224 2 S 16 R 1 S 1 S 
24I/RA May 2017 b.asp.e ST10 2 S 8 S 1 S 1 S 
25I/RA June 2017 wounde ST10 2 S 4 S 1 S 1 S 
26O/RN June 2017 urine ST131 2 S 8 S 1 S 1 S 
a MLST: multilocus sequence types.
b Antimicrobial drugs abbreviations: COL-colistin, AMK-amikacin, AMX/CLAV-a
imipenem, MEM-meropenem, PIP/TZB-piperacillin/tazobactam, CIP-ciprofloxacin, GEN
intermediate, R-resistant.
c ESbL+: extended spectrum beta-lactamase-producing isolate.
d CTX-M group1.
e b. asp.: bronchial aspirate.antibiotic resistance markers were investigated by multiplex
tandem PCR CRE assay (AusDiagnostics, Mascot – NSW, Australia)
among mcr-1 positive E. coli isolates and on the strain of S. enterica
isolated in 2015: CTX-M group 1 target was detected on 19O/CE
strain, according to the phenotypic antimicrobial susceptibility.
Out of the Enterobacteriaceae isolates, the colistin resistance
rate was 0.47%, about a quarter of the one reported by a large study
of strains isolated worldwide from 2014 to 2015 (SENTRY Program)
(Castanheira et al., 2016). The overall prevalence rate of mcr-1
positive enterobacterial strains (0,14%) is similar to that observed
by the Program. The prevalence of mcr-1 among colistin-resistant E
.coli isolates was 41%, more elevated than that registered by
SENTRY.
All the 26 mcr-1 harboring E. coli were subjected to multilocus
sequence types (MLST) analysis. PCR amplification and sequencing
were performed following the protocols specified at the E. coli
MLST website (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). The
analyzed strains were assigned to 13 distinct sequence types
(STs), notably 8 strains belonged to 8 different STs, as detailed in
Table 1. Additionally, the finding of several mcr-1 carrying E. coli
isolates belonging to STs associated with environment, animals,
food and feed products according to the MLST database (http://
mlst.warwick.ac.uk/mlst/dbs/Ecoli/GetTableInfo_htm) is in agree-
ment with a likely nonhuman origin of the mcr-1 determinant.
One important question refers to the potential role of food-
producing animals in the epidemiology of Enterobacteriaceae
carrying the mcr-1 gene. Colistin has been widely used for decades
in veterinary medicine both as a prophylactic agent and for
treatment of food-producing animals. In 2013, polymyxins (mainly
colistin) were the 5th most sold group of antimicrobials based on
the total sales of polymyxins in the 26 EU/EEA countries reporting
data. Notably, Italy is the European Member State with the secondek2.
FEP IMI MEM PIP/TZB CIP GEN SXT TGC COL
1 S 0.25 S 0.25 S 4 S 0.25 S 1 S 20 S 0.5 S 8 R
1 S 0.25 S 0.25 S 8 S 4 R 1 S 320 R 0.5 S 8 R
2 I 0.25 S 0.25 S 4 S 4 R 16 R 20 S 0.5 S 8 R
1 S 0.25 S 0.25 S 4 S 4 R 1 S 320 R 0.5 S 4 R
1 S 0.25 S 0.25 S 64 R 4 R 2 S 320 R 0.5 S 8 R
1 S 0.25 S 0.25 S 4 S 4 R 1 S 320 R 1 S 8 R
1 S 0.25 S 0.25 S 4 S 0.25 S 1 S 320 R 0.5 S 8 R
1 S 0.25 S 0.25 S 4 S 4 R 16 R 320 R 0.5 S 8 R
1 S 0.25 S 0.25 S 4 S 2 R 1 S 320 R 0.5 S 8 R
1 S 0.25 S 0.25 S 4 S 4 R 16 R 320 R 0.5 S 8 R
1 S 0.25 S 0.25 S 4 S 4 R 16 R 320 R 0.5 S 8 R
1 S 0.25 S 0.25 S 4 S 4 R 16 R 320 R 0.5 S 8 R
1 S 0.25 S 0.25 S 16 I 4 R 1 S 320 R 0.5 S 8 R
1 S 0.25 S 0.25 S 16 I 4 R 1 S 320 R 0.5 S 4 R
1 S 0.25 S 0.25 S 4 S 0.25 S 1 S 320 R 0.5 S 8 R
1 S 0.25 S 0.25 S 4 S 2 R 16 R 320 R 0.5 S 8 R
1 S 0.25 S 0.25 S 4 S 0.25 S 1 S 320 R 0.5 S 4 R
1 S 0.25 S 0.25 S 4 S 4 R 1 S 320 R 0.5 S 8 R
2 I 0.25 S 0.25 S 4 S 0.25 S 1 S 320 R 0.5 S 8 R
1 S 0.25 S 0.25 S 4 S 1 I 1 S 320 R 0.5 S 8 R
1 S 0.25 S 0.25 S 4 S 4 R 1 S 20 S 0.5 S 16 R
1 S 0.25 S 0.25 S 4 S 4 R 1 S 20 S 0.5 S 8 R
1 S 0.25 S 0.25 S 4 S 0.25 S 1 S 320 R 0.5 S 4 R
1 S 0.25 S 0.25 S 4 S 0.25 S 1 S 320 R 0.5 S 4 R
1 S 0.25 S 0.25 S 4 S 0.25 S 1 S 320 R 0.5 S 4 R
1 S 0.25 S 0.25 S 4 S 0.25 S 1 S 320 R 0.5 S 6 R
moxicillin/clavulanic acid,CTX-cefotaxime, CFT-ceftazidime, FEP-cefepime, IMI-
-gentamicin, STX-trimethoprim-sulfamethoxazole, TGC-tgecyline. S-susceptible, I-
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Medicines Agency, 2014). The mcr-1 carrying plasmids can be
maintained stably and disseminate more rapidly under the
selective pressure imposed by the use of colistin. Emilia-Romagna
is the second Italian region for poultry production, with over 1,100
farms, 36 million heads and a value of production (meat and eggs)
of over 600 million euros. The role of Romagna in the national
poultry landscape is of paramount relevance. This district covers
20% of Italian poultry production,11% of eggs, and it aggregates 40%
of the products processing and marketing division. A retrospective
analysis performed on human and veterinary Salmonella spp.
isolates in Emilia Romagna demonstrated the presence of mcr-1 in
Salmonella isolates at least since 2012 in our territory. mcr-1-
positive isolates of human origin were concentrated in 2015, while
the largest number of isolates of animals origin was concentrated
over the previous two years (Carnevali et al., 2016). The presence of
Salmonella spp. and E. coli in poultry is considered a risk factor for
human consumption of meat and eggs. Antimicrobial resistant
zoonotic pathogens present in meat food represent a direct hazard
to public health. Moreover antimicrobial resistance genes in
commensal or pathogenic zoonotic strains form an indirect risk, as
they increase the gene pool from which pathogenic bacteria can
pick up resistance determinants. Nowadays it is well known that
Salmonella spp. and E. coli could act as donors of antimicrobial
resistance genes for other enteric bacilli (Verraes et al., 2013).
Therefore an integrated animal, human and environmental health
surveillance system is essential to monitor the mcr-1 emergence
and diffusion in our area.
The distribution of plasmid-borne colistin resistance determi-
nants represents a concern for the infection prevention and public
health, especially in the context of high CRE prevalence in hospital
wards. mcr-1 was found to be co-localized with other resistance
genes on plasmids, such as extended-spectrum b-lactamase
(ESBLs) and carbapenemase genes. This means that the mcr-1
carrying plasmids can be maintained stably and disseminate more
rapidly under the selective pressure imposed by the use of
antimicrobial agents other than colistin. Klebsiella pneumoniae
carbapenemases (KPCs) have spread among Gram-negative
bacteria, especially K. pneumoniae. KPC-producing K. pneumoniae
is endemic in Italy, and the prevalence rate is around 85% of the
total K. pneumoniae isolates in some Romagna hospital wards. In
addition to this, the percentage of KPC-producing E. coli isolates
has doubled in the three-year period 2015-2017, reaching 0,6% in
2017. The spread of the mcr-1 gene to KPC-producing human
pathogenic bacteria could pose a real threat because colistin is
considered to be the last-resort antibiotic used for the treatment of
infections caused by MDR-gram negative bacteria.
There are very limited data on dissemination of mobile colistin
resistance genes in Italy, in particular in humans. To ourknowledge, this is the first laboratory surveillance program that
screened colistin resistant Enterobacteriaceae isolated from human
specimens for the mcr-1/2/3/4/5 determinants. Our study reports
on the occurrence of mcr-1-harboring strains among clinical
isolates and the mcr-1 prevalence rate in the Romagna area. On the
other hand, it is advisable to establish an integrated animal, human
and environmental survey system in order to monitor the mcr-1
diffusion in our area.
The knowledge of the mcr prevalence among colonized subjects
and infected patients would allow evaluation of the dissemination
of colistin resistant genes in our area, with the aim of reducing any
related risk.
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